Proactive Investors - Run By Investors For Investors

Totally sees a win for shareholders, NHS and patients from Vocare acquisition

The deal marks a huge step up for Totally, which boasted sales of £3.7mln in its latest half year
picture of patient
More patients are set to be treated outside of hospital

We are approaching the time of year when photos of people in corridors in hospital A&E units waiting to be treated traditionally hit the front pages.

If nothing else, it’s a reminder of the pressure the NHS is under and that a solution to tackle the country’s expanding health care requirements has yet to be found.

This growing demand is also a prime reason why AIM-listed Totally PLC (LON:TLY) has just acquired Vocare, one of the UK’s largest urgent care, 111 helpline operators and GP out-of-office service providers.

WATCH: Totally keen to extend footprint in growing urgent care market

The deal marks a huge step up for Totally, which boasted sales of £3.7mln in its latest half year. Revenues came mostly from three acquisitions made in 2016.

Vocare, though, has sales of nearly £80mln, a workforce of almost 2,000 and contracts in 11 NHS regions.

And rather like the NHS, Vocare has had problems.

Improvements underway

In three areas the Care Quality Commission (CQC), the regulator of care services in the UK, recently marked its service inadequate while in two others there was a recommendation that improvement was needed.

A red flag? Not according to Wendy Lawrence, Totally’s chief executive, who believes the CQC reports helped its own due diligence.

“The CQC audits are very detailed. There should be no more surprises as it has gone over everything,” she told Proactive.

Totally was not in charge when the problems occurred (it completed the acquisition two weeks ago) and Lawrence says action has already been taken to improve performance.

Leadership and inadequate processes and systems were at the root but Vocare’s clinical care was rated ‘good’ by the CQC, she points out.

“We have added to a solid clinical governance framework, both at managerial and director level, alongside experienced clinical managers who are used to working with CQC.

“We are also working with the staff in areas that need improvement, and supporting them to make the changes required.”

The structure of the deal now means only £6.5mln of the £11mln consideration will be paid upfront in cash to ensure the owners, who are staying on, are incentivised.

Buy and build

Totally sees Vocare as the hub of an out-of-hospital care ‘buy and build’ strategy.

New guidance this year for the commissioning of integrated urgent care services by the NHS will make them even more important.

At present, the clinical commissioning groups (CCGs) that award contracts for the NHS can put out to tender each of the 111 helpline, urgent care and out-of hours GP services separately, which usually results in different providers for each service.

Going forward, CCGs have to tender for Integrated Urgent Care Services and therefore a single organisation will be able to provide all three services.

Vocare is one of only of a few companies currently approved for the entire range of urgent care, 111 and out-of-hours services.

Added to its presence in most of the NHS’s operating regions, this presents a ‘massive opportunity’ for Totally.

NHS a huge outsourcer

Lawrence, who spent more than 20 years working in the health service, says patients don’t appreciate how much the NHS outsources already.

The annual outsourcing budget for the NHS back in 2014 was £20bn annually and has increased year on year since that time, but even those colossal sums are proving to be inadequate.

“The health service cannot cope with the level of demand placed on it, which is only going to grow with an ageing population, greater co-morbidity of long term conditions such as diabetes and obesity and people generally living longer.

“A lot of these people don’t need to be in hospital and should be supported with care closer to their homes and helped to better self manage their health and well-being”

Vocare a big deal

But will Totally be able to cope with an operation as large as Vocare?

Growth at the newly acquired business has been rapid.

Revenues rose to £76.8mln in the year to March from £32.4mln two years earlier or 137% over the period.

That pace of growth may have been behind Vocare’s recent problems, but Lawrence believes the three acquisitions Totally made in 2016 have provided valuable lessons it can draw on.

Premier Physical and Optimum Sports are both independent physiotherapist service providers while About Health is an out-of-hospital dermatology, and referral management services provider.

Dependent on their performance, the final consideration for the trio might rise to £15.1mln.

Totally’s interim losses this year were just shy of £1mln, but with the addition of Vocare, brokers believe a small underlying profit is possible in the year end March 2018 –  the new year end following the acquisition.

Broker Cenkos is predicting underlying profits [EBITDA] of about £1mln for the following year to March 2019.

More deals likely

A funding in March ahead of the Vocare deal raised £17.6mln at 55p, which was more than planned and has given some leeway for further deals.

Lawrence said another purchase was under consideration at the time it was looking at Vocare and this may go ahead early in 2018.

No other details yet, but another provider of out-of-hospital services would seem likely as Lawrence sees this as a market that is only going to grow given the strain on the NHS.

“As long as people receive the care they want, where they want it and at the time they want it, they don’t mind where it comes from.”

Totally is valued at £21mln at 35.5p.

View full TLY profile View Profile

Totally Plc Timeline

February 14 2018
January 31 2018
January 12 2018
January 09 2018
November 30 2017
November 29 2017
July 23 2015

Related Articles

September 20 2017
The Cello Health unit led the way as it grew organically and via the acquisition of Defined Health
February 13 2018
The shares are up 50% over the last year as the company's international expansion gains momentum
Media junkie
February 13 2018
In modern parlance, Ebiquity is making a pivot towards becoming the "world's leading tech-enabled marketing and media analytics consultancy"

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use